Compare IRWD & BBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRWD | BBSI |
|---|---|---|
| Founded | 1998 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 663.6M | 748.3M |
| IPO Year | 2009 | 1994 |
| Metric | IRWD | BBSI |
|---|---|---|
| Price | $4.84 | $29.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $7.67 | ★ $42.67 |
| AVG Volume (30 Days) | ★ 1.8M | 137.1K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.01% |
| EPS Growth | ★ 1400.00 | 5.05 |
| EPS | 0.15 | ★ 2.08 |
| Revenue | $298,276,000.00 | ★ $920,432,000.00 |
| Revenue This Year | $57.95 | $6.59 |
| Revenue Next Year | $4.39 | $6.05 |
| P/E Ratio | $31.07 | ★ $14.57 |
| Revenue Growth | 8.88 | ★ 9.50 |
| 52 Week Low | $0.55 | $25.33 |
| 52 Week High | $5.78 | $49.65 |
| Indicator | IRWD | BBSI |
|---|---|---|
| Relative Strength Index (RSI) | 68.15 | 43.44 |
| Support Level | $3.07 | $28.11 |
| Resistance Level | $5.67 | $29.49 |
| Average True Range (ATR) | 0.26 | 0.72 |
| MACD | 0.07 | -0.03 |
| Stochastic Oscillator | 96.55 | 7.55 |
Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.
Barrett Business Services Inc is a provider of business management solutions for small and mid-sized companies through a platform that combines management consulting expertise with human resource tools to help business owners manage and operate their businesses more effectively. The company has two categories of services: Professional Employer Services (PEO) and Staffing. The majority of revenue is derived from the Professional Employer Services segment, which provides clients with human resource advisory services, HRIS access, retirement plans, a learning management system, and a web-based technology platform, myBBSI.